Salesforce CRM Form 4 shows RSU conversion and 4,081 shares held
Rhea-AI Filing Summary
Salesforce, Inc. reported an insider equity transaction involving director Sachin Mehra. On 11/22/2025, 274 restricted stock units were converted into 274 shares of Salesforce common stock at an exercise price of $0, increasing his directly held common stock position to 4,081 shares. The filing notes that these restricted stock units convert to common stock on a one-for-one basis and vest in four equal installments on February 22, May 22, August 22, and November 22, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 274 | $0.00 | -- |
| Exercise | Common Stock | 274 | $0.00 | -- |
Footnotes (1)
- Restricted Stock Units convert to shares of common stock on a one-for-one basis. These restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.
FAQ
What insider transaction did Salesforce (CRM) disclose in this Form 4?
The filing shows director Sachin Mehra converted 274 restricted stock units into 274 shares of Salesforce common stock on 11/22/2025 at an exercise price of $0.
What are the vesting terms of the Salesforce (CRM) restricted stock units in this filing?
The restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025, and convert to common stock on a one-for-one basis.
What type of derivative security is reported for Salesforce (CRM) in this Form 4?
The derivative security reported is restricted stock units, which have a stated conversion or exercise price of $0 and are settled in Salesforce common stock.
Who signed the Salesforce (CRM) Form 4 and in what capacity?
The Form 4 was signed by /s/ Sarah Dale acting as Attorney-in-Fact for Sachin Mehra on 11/24/2025.